ORTEXORTEX News
Tracking IBKR? Get live short interest, options flow, and signals on ORTEX.Sign up free →
IB
Trader NoteIBKR

IBKR Shorts Build Into July Earnings

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 2 min readdata as of 10 Jun 2026, 19:05

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Interactive Brokers Group heads into its July 14 earnings date with short interest climbing at the fastest pace in months while the broader stock drifts lower — a combination that sharpens the setup ahead of the next print.

The most striking data point this week is the pace of short-side accumulation. Short interest jumped nearly 15% in a single session on June 9, lifting the total to 2.94% of the free float — up roughly 30% from a month ago. That brings the position to its highest level in the 30-day window. The direction is unambiguous: shorts have been rebuilding steadily since early May, when the float-adjusted figure was closer to 2.3%. At the same time, borrowing costs remain negligible at 0.48%, and availability is extraordinarily loose at over 6,600% — meaning there are roughly 66 shares available to borrow for every one already shorted. The lending market places zero friction on that position-building. The ORTEX short score ticked up to 33.8 on June 9, a fresh high for the recent run, though it remains in moderate territory overall.

Options traders have nudged slightly more defensive this week, though the move is modest. The put/call ratio hit 0.67, running a little above its 20-day average of 0.63 — about 1.6 standard deviations high, but well within normal range. The 52-week PCR high of 9.3 sets a dramatic contrast: whatever caution exists now is minor relative to past stress episodes. On the factor side, EPS momentum scores in the upper-60s percentile range, and the short-score rank lands at 56 — neither stretched nor calm.

The Street remains broadly constructive, though last-published analyst actions date from late April following Q1 results. The post-earnings round of target raises — Goldman lifting to $98, Barclays and BMO both moving to $93 — left the consensus mean price target near $88, offering modest upside from the current $86.33. The PE multiple near 32x has compressed slightly over seven days. Bulls point to the record Q1 trading volumes and margin lending growth; the bear case centres on forward EPS estimates that have been revised lower and a quality factor that has slipped since May.

Insider activity from May 8 warrants a note. CEO Milan Galik sold 255,039 shares at $84.42 — a transaction worth over $21 million — on the same day the CFO sold $7 million and the CIO sold $2.7 million. The cluster of C-suite selling on a single date is the kind of coordinated disclosure that typically follows a planned trading programme, but the net 90-day insider position still shows net selling of roughly $36 million across the executive group. Director Lori Conkling's recurring small purchases ($1,700–$2,200 per month) run against the grain but are too small to move the needle on sentiment.

Peer performance this week adds context: HOOD fell 5% over the same period, and BULL dropped more than 11%. IBKR's 2.7% weekly decline is comparatively contained, suggesting the recent short-side build may reflect sector-wide caution on brokerage names rather than a stock-specific thesis. The July 14 earnings date is the next hard catalyst — and after back-to-back post-earnings day-one declines of roughly 1.9% and 3.9% in prior quarters, the question is whether the rebuilt short position reflects that earnings-reaction pattern or something more durable.

Stocks in this article

See the live data behind this article on ORTEX.

Open IBKR on ORTEX →

How this article was generated

Generated
10 Jun 2026, 19:14
Data as of
10 Jun 2026, 19:05
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notes

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.